Probiotic mixture in patients after Helicobacter pylori eradication : a real-life experience
BACKGROUND: Eradication for Helicobacter pylori usually induces digestive dysbiosis that, in turn, elicits symptoms. Consequently, probiotic supplementation may counterbalance the disturbed microbiota after this procedure. So, probiotics may restore microbiota homeostasis quickly relieve complaints.
METHODS: The current study evaluated the efficacy and safety of Abivisor®, a food supplement containing Lacticaseibacillus rhamnosus LR06 (3 billion living cells), Lactiplantibacillus pentosus LPS01(100 million living cells), Lactiplantibacillus plantarum LP01 (1 billion living cells), and N-acetyl cysteine (60 mg). Patients were randomized into two groups (2:1). Group A took one stick/daily for 60 days after eradication. Group B was considered as control. Patients were evaluated at baseline (T0) and after 15 (T1), 30 (T2), and 60 (T3) days. The severity of digestive symptoms was measured by patients using a Visual Analog Scale. The percentage of patients with each symptom was also evaluated.
RESULTS: Abivisor® has significantly and progressively diminished intestinal symptoms' presence and severity at T1, T2, and even more at T3. Accordingly, the percentage of symptomatic patients diminished more rapidly and significantly in group A than in B. All patients well tolerated the food supplement.
CONCLUSIONS: The present study suggests that Abivisor® may be an effective and safe therapeutic option for managing patients undergoing H. pylori eradication.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - year:2024 |
---|---|
Enthalten in: |
Minerva gastroenterology - (2024) vom: 26. März |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Aragona, Salvatore E [VerfasserIn] |
---|
Links: |
---|
Themen: |
---|
Anmerkungen: |
Date Revised 27.03.2024 published: Print-Electronic Citation Status Publisher |
---|
doi: |
10.23736/S2724-5985.24.03634-9 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM370256484 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM370256484 | ||
003 | DE-627 | ||
005 | 20240328001336.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240328s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.23736/S2724-5985.24.03634-9 |2 doi | |
028 | 5 | 2 | |a pubmed24n1351.xml |
035 | |a (DE-627)NLM370256484 | ||
035 | |a (NLM)38536095 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Aragona, Salvatore E |e verfasserin |4 aut | |
245 | 1 | 0 | |a Probiotic mixture in patients after Helicobacter pylori eradication |b a real-life experience |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 27.03.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status Publisher | ||
520 | |a BACKGROUND: Eradication for Helicobacter pylori usually induces digestive dysbiosis that, in turn, elicits symptoms. Consequently, probiotic supplementation may counterbalance the disturbed microbiota after this procedure. So, probiotics may restore microbiota homeostasis quickly relieve complaints | ||
520 | |a METHODS: The current study evaluated the efficacy and safety of Abivisor®, a food supplement containing Lacticaseibacillus rhamnosus LR06 (3 billion living cells), Lactiplantibacillus pentosus LPS01(100 million living cells), Lactiplantibacillus plantarum LP01 (1 billion living cells), and N-acetyl cysteine (60 mg). Patients were randomized into two groups (2:1). Group A took one stick/daily for 60 days after eradication. Group B was considered as control. Patients were evaluated at baseline (T0) and after 15 (T1), 30 (T2), and 60 (T3) days. The severity of digestive symptoms was measured by patients using a Visual Analog Scale. The percentage of patients with each symptom was also evaluated | ||
520 | |a RESULTS: Abivisor® has significantly and progressively diminished intestinal symptoms' presence and severity at T1, T2, and even more at T3. Accordingly, the percentage of symptomatic patients diminished more rapidly and significantly in group A than in B. All patients well tolerated the food supplement | ||
520 | |a CONCLUSIONS: The present study suggests that Abivisor® may be an effective and safe therapeutic option for managing patients undergoing H. pylori eradication | ||
650 | 4 | |a Journal Article | |
700 | 1 | |a Fabbri, Carlo |e verfasserin |4 aut | |
700 | 1 | |a Cammarota, Giovanni |e verfasserin |4 aut | |
700 | 1 | |a Ciprandi, Giorgio |e verfasserin |4 aut | |
700 | 0 | |a HERADY Study Group |e verfasserin |4 aut | |
700 | 1 | |a Allegretta, Leonardo |e investigator |4 oth | |
700 | 1 | |a Annicchiarico, Raffaele |e investigator |4 oth | |
700 | 1 | |a Bertino, Antonino |e investigator |4 oth | |
700 | 1 | |a Bibbò, Stefano |e investigator |4 oth | |
700 | 1 | |a Bordonaro, Antonio |e investigator |4 oth | |
700 | 1 | |a Buda, Carmelo |e investigator |4 oth | |
700 | 1 | |a Calabrese, Federica |e investigator |4 oth | |
700 | 1 | |a Camilleri, Salvatore |e investigator |4 oth | |
700 | 1 | |a Cautela, Giuseppe |e investigator |4 oth | |
700 | 1 | |a Cecere, Amedeo |e investigator |4 oth | |
700 | 1 | |a Centenara, Laura |e investigator |4 oth | |
700 | 1 | |a Cocco, Andrea |e investigator |4 oth | |
700 | 1 | |a Conte, Elisabetta |e investigator |4 oth | |
700 | 1 | |a Crovaro, Marco |e investigator |4 oth | |
700 | 1 | |a Cuccu, Marianna |e investigator |4 oth | |
700 | 1 | |a Curro', Enrico |e investigator |4 oth | |
700 | 1 | |a DE Nucci, Germana |e investigator |4 oth | |
700 | 1 | |a Benedetto, Emanuele Di |e investigator |4 oth | |
700 | 1 | |a DI Martino, Vincenzo |e investigator |4 oth | |
700 | 1 | |a D'Onofrio, Vittorio |e investigator |4 oth | |
700 | 1 | |a Eusebi, Leonardo H |e investigator |4 oth | |
700 | 1 | |a Ferrini, Luciano |e investigator |4 oth | |
700 | 1 | |a Ferro, Giuseppina |e investigator |4 oth | |
700 | 1 | |a Ficuccilli, Fabrizio |e investigator |4 oth | |
700 | 1 | |a Francia, Chiara |e investigator |4 oth | |
700 | 1 | |a Geraci, Girolamo |e investigator |4 oth | |
700 | 1 | |a Grassia, Roberto |e investigator |4 oth | |
700 | 1 | |a Guardascione, Francesco |e investigator |4 oth | |
700 | 1 | |a Incarbone, Salvatore |e investigator |4 oth | |
700 | 1 | |a Licci, Claudio |e investigator |4 oth | |
700 | 1 | |a Lisotti, Andrea |e investigator |4 oth | |
700 | 1 | |a Magistroni, Marco |e investigator |4 oth | |
700 | 1 | |a Magrì, Giovanni |e investigator |4 oth | |
700 | 1 | |a Marquez, Rita |e investigator |4 oth | |
700 | 1 | |a Martini, Sabina |e investigator |4 oth | |
700 | 1 | |a Masoni, Luigi |e investigator |4 oth | |
700 | 1 | |a Mazzuca Mari, Vincenzo |e investigator |4 oth | |
700 | 1 | |a Miculan, Federica |e investigator |4 oth | |
700 | 1 | |a Mileti, Alessia |e investigator |4 oth | |
700 | 1 | |a Militello, Carmelo |e investigator |4 oth | |
700 | 1 | |a Minelli, Leonardo |e investigator |4 oth | |
700 | 1 | |a Montebianco Abenavoli, Ludovico |e investigator |4 oth | |
700 | 1 | |a Morando, Federica |e investigator |4 oth | |
700 | 1 | |a Morisco, Stella |e investigator |4 oth | |
700 | 1 | |a Napoletano, Domenico |e investigator |4 oth | |
700 | 1 | |a Ormando, Vittorio M |e investigator |4 oth | |
700 | 1 | |a Palma, Antonio |e investigator |4 oth | |
700 | 1 | |a Palma, Rossella |e investigator |4 oth | |
700 | 1 | |a Papadopoli, Giovanni |e investigator |4 oth | |
700 | 1 | |a Parodi, Andrea |e investigator |4 oth | |
700 | 1 | |a Pironti, Eliseo |e investigator |4 oth | |
700 | 1 | |a Polimeni, Natale |e investigator |4 oth | |
700 | 1 | |a Raguzzi, Ivana |e investigator |4 oth | |
700 | 1 | |a Rigante, Antonella |e investigator |4 oth | |
700 | 1 | |a Romano, Maurizio |e investigator |4 oth | |
700 | 1 | |a Ruggiero, Simon |e investigator |4 oth | |
700 | 1 | |a Sanalitro, Angelo |e investigator |4 oth | |
700 | 1 | |a Savastano, Antonella |e investigator |4 oth | |
700 | 1 | |a Schicchi, Angelo |e investigator |4 oth | |
700 | 1 | |a Selvaggio, Corrado |e investigator |4 oth | |
700 | 1 | |a Sigillito, Angelo |e investigator |4 oth | |
700 | 1 | |a Silla, Michele |e investigator |4 oth | |
700 | 1 | |a Solida, Eleonora |e investigator |4 oth | |
700 | 1 | |a Tarocchi, Mirko |e investigator |4 oth | |
700 | 1 | |a Trecca, Antonello |e investigator |4 oth | |
700 | 1 | |a Trincas, Efisio |e investigator |4 oth | |
700 | 1 | |a Troina, Graziano |e investigator |4 oth | |
700 | 1 | |a Vannella, Lucy |e investigator |4 oth | |
700 | 1 | |a Vitale, Luigi M |e investigator |4 oth | |
700 | 1 | |a Zaru, Salvatore |e investigator |4 oth | |
773 | 0 | 8 | |i Enthalten in |t Minerva gastroenterology |d 2021 |g (2024) vom: 26. März |w (DE-627)NLM305903195 |x 2724-5365 |7 nnns |
773 | 1 | 8 | |g year:2024 |g day:26 |g month:03 |
856 | 4 | 0 | |u http://dx.doi.org/10.23736/S2724-5985.24.03634-9 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |j 2024 |b 26 |c 03 |